These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3735088)

  • 1. Methods for in vitro percutaneous absorption studies. VI: Preparation of the barrier layer.
    Bronaugh RL; Stewart RF
    J Pharm Sci; 1986 May; 75(5):487-91. PubMed ID: 3735088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell.
    Bronaugh RL; Stewart RF
    J Pharm Sci; 1985 Jan; 74(1):64-7. PubMed ID: 3981421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for in vitro percutaneous absorption studies III: hydrophobic compounds.
    Bronaugh RL; Stewart RF
    J Pharm Sci; 1984 Sep; 73(9):1255-8. PubMed ID: 6491945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro percutaneous absorption in mouse skin: influence of skin appendages.
    Kao J; Hall J; Helman G
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):93-103. PubMed ID: 3376118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous absorption of benzo[a]pyrene in the rat: comparison of in vivo and in vitro results.
    Yang JJ; Roy TA; Mackerer CR
    Toxicol Ind Health; 1986 Dec; 2(4):409-16. PubMed ID: 3590196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous absorption and metabolism of pyrene, benzo[a]pyrene, and di(2-ethylhexyl) phthalate: comparison of in vitro and in vivo results in the hairless guinea pig.
    Ng KM; Chu I; Bronaugh RL; Franklin CA; Somers DA
    Toxicol Appl Pharmacol; 1992 Aug; 115(2):216-23. PubMed ID: 1641855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin.
    Bronaugh RL; Stewart RF; Simon M
    J Pharm Sci; 1986 Nov; 75(11):1094-7. PubMed ID: 3820104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous absorption of [14C]DDT and [14C]benzo[a]pyrene from soil.
    Wester RC; Maibach HI; Bucks DA; Sedik L; Melendres J; Liao C; DiZio S
    Fundam Appl Toxicol; 1990 Oct; 15(3):510-6. PubMed ID: 2258015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: an in vitro study with benzo[a]pyrene and testosterone.
    Kao J; Patterson FK; Hall J
    Toxicol Appl Pharmacol; 1985 Dec; 81(3 Pt 1):502-16. PubMed ID: 3936234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of skin source, penetration cell fluid, and partition coefficient on in vitro skin penetration.
    Hawkins GS; Reifenrath WG
    J Pharm Sci; 1986 Apr; 75(4):378-81. PubMed ID: 3723358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of percutaneous absorption of fragrances by humans and monkeys.
    Bronaugh RL; Stewart RF; Wester RC; Bucks D; Mailbach HI; Anderson J
    Food Chem Toxicol; 1985 Jan; 23(1):111-4. PubMed ID: 4038674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for in vitro percutaneous absorption studies V: Permeation through damaged skin.
    Bronaugh RL; Stewart RF
    J Pharm Sci; 1985 Oct; 74(10):1062-6. PubMed ID: 4078703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive accuracy of in vitro measurements for the dermal absorption of a lipophilic penetrant (fluazifop-butyl) through rat and human skin.
    Ramsey JD; Woollen BH; Auton TR; Scott RC
    Fundam Appl Toxicol; 1994 Aug; 23(2):230-6. PubMed ID: 7982531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of experimental conditions on absorption of glycol ethers through human skin in vitro.
    Wilkinson SC; Williams FM
    Int Arch Occup Environ Health; 2002 Oct; 75(8):519-27. PubMed ID: 12373313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous absorption of trinitrobenzene: animal models for human skin.
    Kraeling ME; Reddy G; Bronaugh RL
    J Appl Toxicol; 1998; 18(6):387-92. PubMed ID: 9840746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Hydroxybenzo(a)pyrene as a biomarker of dermal exposure to benzo(a)pyrene.
    Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Wathier L; Ferrari E
    Arch Toxicol; 2009 Sep; 83(9):873-83. PubMed ID: 19526226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous penetration and skin retention of topically applied compounds: an in vitro-in vivo study.
    Reifenrath WG; Hawkins GS; Kurtz MS
    J Pharm Sci; 1991 Jun; 80(6):526-32. PubMed ID: 1941541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies.
    Davies DJ; Ward RJ; Heylings JR
    Toxicol In Vitro; 2004 Jun; 18(3):351-8. PubMed ID: 15046783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics.
    Bronaugh RL; Stewart RF; Storm JE
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):534-43. PubMed ID: 2749738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo percutaneous absorption of retinol from cosmetic formulations: significance of the skin reservoir and prediction of systemic absorption.
    Yourick JJ; Jung CT; Bronaugh RL
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):117-21. PubMed ID: 18511092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.